Volume 27, Number 11—November 2021
Dispatch
Emergence of Vibrio cholerae O1 Sequence Type 75, South Africa, 2018–2020
Table 2
Strain no. | Serotype | Biotype | AMR phenotype | AMR gene | Plasmids | ctxB allele | tcpA | wbeT mutation† | Lineage‡ |
---|---|---|---|---|---|---|---|---|---|
YA00085869 | Ogawa | El Tor | Pansusceptible | qnrVC4 | None | ctxB1 | tcpAN16961 | WT | L3b.1 |
YA00132994 | Inaba | El Tor | Pansusceptible | qnrVC4 | None | ctxB1 | tcpAN16961 | B08 | L3b.1 |
YA00134463 | Inaba | El Tor | Pansusceptible | qnrVC4 | None | ctxB1 | tcpAN16961 | B08 | L3b.1 |
OA01603367 | Inaba | El Tor | Pansusceptible | qnrVC4 | None | ctxB1 | tcpAN16961 | B08 | L3b.1 |
YA00192016 | Ogawa | El Tor | Pansusceptible | qnrVC4 | None | ctxB1 | tcpAN16961 | WT | L3b.1 |
CF00214281 | Ogawa | El Tor | Pansusceptible | qnrVC4 | None | ctxB1 | tcpAN16961 | WT | L3b.1 |
YA00193061 | Ogawa | El Tor | Pansusceptible | qnrVC4 | None | ctxB1 | tcpAN16961 | WT | L3b.1 |
References
- Mintz ED, Tauxe RV. Cholera in Africa: a closer look and a time for action. J Infect Dis. 2013;208(Suppl 1):S4–7. DOIPubMedGoogle Scholar
- Küstner HG, Gibson IH, Carmichael TR, Van Zyl L, Chouler CA, Hyde JP, et al. The spread of cholera in South Africa. S Afr Med J. 1981;60:87–90.PubMedGoogle Scholar
- Ismail H, Smith AM, Tau NP, Sooka A, Keddy KH; Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa. Cholera outbreak in South Africa, 2008-2009: laboratory analysis of Vibrio cholerae O1 strains. J Infect Dis. 2013;208(Suppl 1):S39–45. DOIPubMedGoogle Scholar
- Mutreja A, Kim DW, Thomson NR, Connor TR, Lee JH, Kariuki S, et al. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature. 2011;477:462–5. DOIPubMedGoogle Scholar
- Weill FX, Domman D, Njamkepo E, Tarr C, Rauzier J, Fawal N, et al. Genomic history of the seventh pandemic of cholera in Africa. Science. 2017;358:785–9. DOIPubMedGoogle Scholar
- Ramamurthy T, Mutreja A, Weill FX, Das B, Ghosh A, Nair GB. Revisiting the global epidemiology of cholera in conjunction with the genomics of Vibrio cholerae. Front Public Health. 2019;7:237. DOIPubMedGoogle Scholar
- Irenge LM, Ambroise J, Mitangala PN, Bearzatto B, Kabangwa RKS, Durant JF, et al. Genomic analysis of pathogenic isolates of Vibrio cholerae from eastern Democratic Republic of the Congo (2014-2017). PLoS Negl Trop Dis. 2020;14:
e0007642 . DOIPubMedGoogle Scholar - Mashe T, Domman D, Tarupiwa A, Manangazira P, Phiri I, Masunda K, et al. Highly resistant cholera outbreak strain in Zimbabwe. N Engl J Med. 2020;383:687–9. DOIPubMedGoogle Scholar
- Wang H, Yang C, Sun Z, Zheng W, Zhang W, Yu H, et al. Genomic epidemiology of Vibrio cholerae reveals the regional and global spread of two epidemic non-toxigenic lineages. PLoS Negl Trop Dis. 2020;14:
e0008046 . DOIPubMedGoogle Scholar - Fonseca EL, Dos Santos Freitas F, Vieira VV, Vicente ACP. New qnr gene cassettes associated with superintegron repeats in Vibrio cholerae O1. Emerg Infect Dis. 2008;14:1129–31. DOIPubMedGoogle Scholar
- Fonseca EL, Vicente ACP. Epidemiology of qnrVC alleles and emergence out of the Vibrionaceae family. J Med Microbiol. 2013;62:1628–30. DOIPubMedGoogle Scholar
- Tu YH, Chen BH, Hong YP, Liao YS, Chen YS, Liu YY, et al. Emergence of Vibrio cholerae O1 sequence type 75 in Taiwan. Emerg Infect Dis. 2020;26:164–6. DOIPubMedGoogle Scholar
- Luo Y, Octavia S, Jin D, Ye J, Miao Z, Jiang T, et al. US Gulf-like toxigenic O1 Vibrio cholerae causing sporadic cholera outbreaks in China. J Infect. 2016;72:564–72. DOIPubMedGoogle Scholar
- Wachsmuth IK, Bopp CA, Fields PI, Carrillo C. Difference between toxigenic Vibrio cholerae O1 from South America and US gulf coast. Lancet. 1991;337:1097–8. DOIPubMedGoogle Scholar
- Domman D, Quilici ML, Dorman MJ, Njamkepo E, Mutreja A, Mather AE, et al. Integrated view of Vibrio cholerae in the Americas. Science. 2017;358:789–93. DOIPubMedGoogle Scholar
Page created: September 10, 2021
Page updated: October 19, 2021
Page reviewed: October 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.